Lyell Immunopharma – Cell Therapy and Solid Tumor Cancers
Liz Homans, CEO of Lyell Immunopharma, discusses how the company is tackling one of the hottest topics in cancer treatment: how to deploy cell therapy t...
293 articles
Liz Homans, CEO of Lyell Immunopharma, discusses how the company is tackling one of the hottest topics in cancer treatment: how to deploy cell therapy t...
Jean-Francois Boileau, MD, MSc, FRCSC, surgical oncologist at Jewish General Hospital Segal Cancer Centre; associate professor of surgery and oncology...
Vivek Subbiah, MD, Associate Professor in the Investigational Cancer Therapeutics department and Center Clinical Medical Director of the Clinical Center...
Screening and earlier detection are key in the fight against cancer. Learn more on Health Professional Radio.
Corey Lawson, Vice President of Product Strategy at Accuray, a company that develops unique market-changing radiotherapy solutions, discusses the fast c...
Marilyn C, stage 4 lung cancer survivor discusses her treatment journey with immunotherapy, how she dealt with the stigma and misinformation associat...
Lisa Barroilhet, Associate Professor in the department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health ...
Ronald Martell, President and CEO at MorphImmune discusses MorphImmune's proprietary platform that enables reprogramming or removal of aberrant cells wi...
Samuel Kim, a thoracic surgeon at Northwestern Medicine discusses the Ambulatory Precision Lung Sparing (A-PLUS) surgery program born from the need to b...
Courtney Bitz, LCSW, MSW, director of Clinical Social Work and Spiritual Care in the Department of Supportive Care Medicine at City of Hope, a comprehen...